Web Results

J&J Wins U.S. Approval for First-in-Class Diabetes Drug - Bloomberg


Mar 30, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry its use in women will be somewhat minimal,” Butler said.

Invokana Wins F.D.A. Approval for Diabetes Treatment - The New ...


Mar 30, 2013 ... New Climate-Friendlier Coolant Has a Catch: It's Flammable ... F.D.A. Approves a New Diabetes Drug From J.&J. ... The drug, Invokana, will be sold by Johnson & Johnson and treats patients with type 2 diabetes in a new way, ...

Invokana: J&J advances a trailblazer in diabetes | FierceBiotech


On its approval, analysts expected peak sales of around $650 million for Invokana, but competitors ... a diabetes drug, and the heads of its Janssen unit hope Invokana's success will ... J&J wins first FDA approval for new class of diabetes drug

FDA Approves First in New Class of Diabetes Drugs - Invokana


Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ... As the first company to win FDA approval, Johnson & Johnson has a leg up on industry rivals developing their own ... More details on the studies will be presented at the American Diabetes Association annual meeting in June.

Johnson & Johnson Pegs Its Long-Term Growth Potential On ...


May 20, 2015 ... J&J has a lofty goal of churning out new blockbusters from its ... new drugs and 40 line extensions for regulatory approval by 2019. ... Many analysts predict the product will be among the company's ... that it is exploring safety concerns regarding diabetes drugs that are in a class known as “SGL2 inhibitors.

Johnson & Johnson Could Tap The Huge Diabetes Market With ...


Mar 8, 2013 ... Johnson & Johnson has been battling with patent cliffs like many in the industry, but ... After this, the European Medicines Agency approval should not be far away . The type 2 diabetes drug had earlier shown strong efficacy in reducing ... Merck, the clear market leader with its blockbuster drugs Januvia and ...

FDA Approves Johnson Johnsons New Diabetes Drug


Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly half of ... Janssen will partner with other Johnson & Johnson companies focused on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.

FDA approves Johnson & Johnson diabetes drug, canagliflozin ...


Mar 29, 2013 ... FDA has approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. The U.S. ...

FDA approves Medtronic's 'artificial pancreas' for diabetes | Reuters


Sep 28, 2016 ... The U.S. Food and Drug Administration, in its approval of the device, the ... Patients will still need to instruct the device to deliver extra insulin for meals ... Johnson & Johnson , Tandem Diabetes Care Inc and Insulet Corp, are ...

Type 2 Diabetes Drugs - SGLT2 Inhibitor Antidiabetics - Drug Dangers


Invokana (canagliflozin) – manufactured by Janssen, a division of Johnson & Johnson ... Diabetes is a medical condition in which the body does not process sugar correctly. ... Farxiga was the first SGLT2 drug the FDA considered for approval. ... Public Citizen has all three medications on its “Do Not Use” list on its website.

More Info

Johnson & Johnson's New Diabetes Drug: A Blockbuster in the ...


Apr 21, 2014 ... Johnson's Invokana is about to face a host of new SGLT2 competitors ... Since Invokana helped lift Johnson's first-quarter sales in the U.S. last quarter, let's look at its ... Express Scripts expects spending on diabetes treatment will grow 11% in ... the first in a new class of diabetes drugs to win FDA ap...

UPDATED: J&J wins first FDA approval for new class of diabetes drug


Mar 29, 2013 ... The approval gives the healthcare giant its first market green light for a new ... Johnson & Johnson ($JNJ) won the agency's nod for Invokana ... with a relatively high rate of genital infections which will limit uptake in our view," ...

J&J faces big spending, big rivals for new diabetes drug Invokana ...


Apr 1, 2013 ... And J&J ($JNJ) will have to spend a pretty penny on detailing and advertising to ... And it's true that diabetes patients often have to change meds to keep control of ... J&J wins first FDA approval for new class of diabetes drug